Emergent BioSolutions
EBS
#6766
Rank
HK$4.94 B
Marketcap
HK$92.63
Share price
-1.24%
Change (1 day)
30.10%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2025 (TTM): HK$10.97

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is HK$10.98. In 2024 the company made an earnings per share (EPS) of -HK$28.26 an increase over its 2023 EPS that were of -HK$115.86.

EPS history for Emergent BioSolutions from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$10.97-138.8%
2024-HK$28.26-75.61%
2023-HK$115.86232.21%
2022-HK$34.87-203.46%
2021HK$33.71-25.09%
2020HK$44.99445.28%
2019HK$8.25-15.2%
2018HK$9.73-35.9%
2017HK$15.1869.57%
2016HK$8.95-27.67%
2015HK$12.3865.63%
2014HK$7.4711.63%
2013HK$6.6932.31%
2012HK$5.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merck
MRK
HK$59.11 438.57%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$3.27-70.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.99 155.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-HK$26.31-339.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39 21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.90-55.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
-HK$25.22-329.79%๐Ÿ‡บ๐Ÿ‡ธ USA